Post-thaw removal of DMSO does not completely abrogate infusional toxicity or the need for pre-infusion histamine blockade

Cytotherapy

Volumn 1, Issue 6, 1999, Pages 439-446

  Rowley, S D ^a   Feng, Z ^a   Yadock, D ^a   Holmberg, L ^a   MacLeod, B ^a   Heimfeld, S ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Cryopreservation; Dimethylsulfoxide; Peripheral blood stem cells; Toxicity; Transplantation

Indexed keywords

EID: 0008377067     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/0032472031000141303     Document Type: Article

References (25)

1. Rowley SD. Hematopoietic stem cell cryopreservation. In: Forman SJ, Blume KG, Thomas ED, editors. Bone marrow transplantation. 2nd ed. Boston MA: Blackwell Scientific Publications, 1999.
2. Davis JM, Rowley SD, Braine HG et al. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990; 75:781-6.
3. Kessinger A, Schmit-Pokorny K, Smith D, Armitage J. Cryopreservation and infusion of autologous peripheral blood stem cells. Bone Marrow Transplant 1990;5(Suppl 1):25-7.
4. Rowley SD, MacLeod B, Heimfeld S, et al. Severe central nervous system toxicity associated with the infusion of cryopreserved peripheral blood stem cell components. Cytotherapy 1999;1:307-13.
5. Stroncek DF, Fautsch SK, Lasky LC et al. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991;31:521-6.
6. Dhodapkar M, Goldberg SL, Tefferi A, Gertz MA. Reversible encephalopathy after cryopreserved peripheral blood stem cell infusion. Am J Hematol 1994;45:187-8.
7. Okamoto Y, Takaue Y, Saito S. et al. Toxicities associated with cryopreserved and thawed peripheral blood stem cell autografts in children with active cancer. Transfusion 1993;33:578-81.
8. Keung Y-K, Lan S, Elkavam U et al. Cardiac arrhythmia after infusion of cryopreserved stem cells. Bone Marrow Transplant 1994;14:363-7.
9. Lopez-Jimenez J, Cervero C, Munoz A et al. Cardiovascular toxicities related to the infusion of cryopreserved grafts: results of a controlled study. Bone Marrow Transplant 1994; 13:789-93.
10. Stayler MJ, Topolsky DL, Crilley PA et al. Transient high grade heart block following autologous bone marrow infusion. Bone Marrow Transplant 1992;10:435-8.
11. David NA. The pharmacology of dimethyl sulfoxide 6544. Ann Rev Pharm 1972;12:353-74.
12. Rowley SD, Bensinger WI, Gooley TA, Buckner CD. Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation. Blood 1994;83:2731-6.
13. Abrams RA, Polacek L, Buck P. Postcryopreservation growth of human CFU-GM: Sequential examination of methodologic factors. Exp Hematol 1985;13:1089-93.
14. Beaujean F, Hartmann O, Kuentz M et al. A simple, efficient washing procedure for cryopreserved human hematopoietic stem cells prior to reinfusion. Bone Marrow Transplant 1991;8:291-4.
15. Kurtzberg J, Laughlin M, Graham ML et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-66.
16. Rubenstein P, Bogrila L, Rosenfeld RE et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995;92:10119-22.
17. Demirer T, Buckner CD, Storer B et al. Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor. J Clin Oncol 1997;15:684-90.
18. Bensinger W, Singer J, Appelbaum F et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 1993;81:3158-63.
19. Schiffman KS, Bensinger WI, Appelbaum FR et al. Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease. Bone Marrow Transplant 1996;17:943-50.
20. Rowley SD, Byrne DV. Low-temperature storage of bone marrow in nitrogen vapor-phase refrigerators: decreased temperature gradients with an aluminum racking system. Transfusion 1992;32:750-4.
21. + cells from blood stem cell components using the Baxter Isolex system. Bone Marrow Transplant 1998;21:1253-62.
22. Attarian H, Bensinger WI, Buckner CD et al. Microbial contamination of peripheral blood stem cell collections. Bone Marrow Transplant 1996;17:699-702.
23. Shpall EJ, LeMaistre CF, Holland K et al. A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy. Blood 1997;90:4313-20.
24. Prezpiorka D, Lu J-G, Anderlini P et al. Debulking blood stem cell collections by density gradient centrifugation in a closed-vessel system. Cytotherapy 1999;1:111-17.
25. Kwekkeboom J, Buurman DE, Ploemacher RE et al. A nylon wool filter coated with human immunoglobulin for rapid depletion of monocytes and myeloid cells from peripheral blood stem cell transplants. Exp Hematol 1998;26:400-8.